Skip to main content
Top
Published in: Abdominal Radiology 11/2018

01-11-2018

Utility of the portal venous phase for diagnosing pancreatic necrosis in acute pancreatitis using the CT severity index

Authors: Yoshifumi Noda, Satoshi Goshima, Keita Fujimoto, Hiroshi Kawada, Nobuyuki Kawai, Yukichi Tanahashi, Masayuki Matsuo

Published in: Abdominal Radiology | Issue 11/2018

Login to get access

Abstract

Purpose

The purpose of the study was to evaluate the value of portal venous phase (PVP) images in the diagnosis of pancreatic necrosis in patients with acute pancreatitis using computed tomography severity index (CTSI).

Methods

This retrospective study was approved by our Institutional Review Board, and written informed consent was waived. Dynamic contrast-enhanced CT images, with the pancreatic parenchymal phase (PPP) and the PVP, were obtained from 56 consecutive patients with acute pancreatitis. Two radiologists reviewed two sets of images, namely PPP images alone (image set A) and combined PPP and PVP images (image set B) to evaluate the CTSI. Cases were categorized as necrotizing pancreatitis if ensuing walled-off necrosis formation was identified 4 weeks after onset of symptoms. The relationship between pancreatic necrosis and CTSI was compared between image sets A and B. Logistic regression analysis was performed to evaluate the significance of clinical and radiological factors associated with the diagnosis of pancreatic necrosis.

Results

Pancreatic necrosis was confirmed in 14 out of 56 (25%) patients. The area under the receiver-operating-characteristic curve (AUC) for the diagnosis of pancreatic necrosis was 0.70 and 0.78 for image sets A and B, respectively. The AUC for image set B was significantly greater than that for image set A (P = 0.0002). Logistic regression analysis demonstrated that among clinical and radiological factors tested, CTSI for image set B was independently correlated with pancreatic necrosis (P = 0.025).

Conclusions

Combined PPP and PVP images significantly improved the diagnostic accuracy of pancreatic necrosis following acute pancreatitis.
Literature
9.
go back to reference Balthazar EJ (2002) Staging of acute pancreatitis. Radiol Clin N Am 40(6):1199–1209CrossRef Balthazar EJ (2002) Staging of acute pancreatitis. Radiol Clin N Am 40(6):1199–1209CrossRef
23.
go back to reference Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN (1993) Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 80(4):484–486CrossRef Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN (1993) Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 80(4):484–486CrossRef
25.
go back to reference Brown A, Orav J, Banks PA (2000) Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 20(4):367–372CrossRef Brown A, Orav J, Banks PA (2000) Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 20(4):367–372CrossRef
Metadata
Title
Utility of the portal venous phase for diagnosing pancreatic necrosis in acute pancreatitis using the CT severity index
Authors
Yoshifumi Noda
Satoshi Goshima
Keita Fujimoto
Hiroshi Kawada
Nobuyuki Kawai
Yukichi Tanahashi
Masayuki Matsuo
Publication date
01-11-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1579-z

Other articles of this Issue 11/2018

Abdominal Radiology 11/2018 Go to the issue

Classics in Abdominal Radiology

The lateral crescent sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine